Tonix Pharmaceuticals stock halted ahead of FDA approval news
John Labate, a director at Solitario Resources Corp. (NYSE:XPL), recently sold 41,667 shares of the company’s stock, according to a filing with the Securities and Exchange Commission. The company, which maintains a FAIR financial health score according to InvestingPro, has shown strong returns over the past five years despite current profitability challenges. The shares were sold at a price of $0.60 each, resulting in a total transaction value of $25,000. Following this sale, Labate holds 223,333 shares of Solitario Resources directly. The transaction was completed on April 1, 2025, with the sale price near the lower end of the company’s 52-week range of $0.55-$0.98. The company maintains a strong liquidity position with a current ratio of 16.28, and investors can access additional insights through InvestingPro, which offers 7 more key tips about XPL’s financial outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.